Santosh Anand
Santosh Anand
Bioinformatician and Data Analyst
Verified email at
Cited by
Cited by
A high-resolution anatomical atlas of the transcriptome in the mouse embryo
G Diez-Roux, S Banfi, M Sultan, L Geffers, S Anand, D Rozado, A Magen, ...
PLoS biology 9 (1), e1000582, 2011
MicroRNA target prediction by expression analysis of host genes
VA Gennarino, M Sardiello, R Avellino, N Meola, V Maselli, S Anand, ...
Genome research 19 (3), 481-490, 2009
Dynamic regulation of the transcription initiation landscape at single nucleotide resolution during vertebrate embryogenesis
C Nepal, Y Hadzhiev, C Previty, V Haberle, N Li, H Takahashi, AM Suzuki, ...
Genome Research, 2013
Next Generation Sequencing of Pooled Samples: Guideline for Variants’ Filtering
S Anand, E Mangano, N Barizzone, R Bordoni, M Sorosina, F Clarelli, ...
Scientific Reports 6, 33735, 2016
SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors
E Milan, C Lazzari, S Anand, I Floriani, V Torri, C Sorlini, V Gregorc, ...
Journal of proteomics 76, 91-101, 2012
Global environmental issues
SV Anand
Open Access Scientific Reports 2 (2), 1-9, 2013
Neoadjuvant therapy in resectable pancreatic cancer: a critical review
C Belli, S Cereda, S Anand, M Reni
Cancer treatment reviews 39 (5), 518-524, 2013
The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
S Mishra, C Bernal, M Silvano, S Anand, A Ruiz i Altaba
Oncogene 38 (29), 5817-5837, 2019
Progresses Toward Precision Medicine in RET-altered Solid Tumors
C Belli, S Anand, JF Gainor, F Penault-Llorca, V Subbiah, A Drilon, ...
Clinical Cancer Research 26 (23), 6102-6111, 2020
High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites
L Vanzan, H Soldati, V Ythier, S Anand, SMG Braun, N Francis, R Murr
Nature Communications 12 (1), 3337, 2021
Development and validation of a serum metabolomic signature for endometrial cancer screening in postmenopausal women
J Troisi, A Raffone, A Travaglino, G Belli, C Belli, S Anand, L Giugliano, ...
JAMA Network Open 3 (9), e2018327-e2018327, 2020
Heterogeneous CD3 expression levels in differing T cell subsets correlate with the In vivo Anti-CD3–mediated T cell modulation
A Valle, G Barbagiovanni, T Jofra, A Stabilini, L Perol, A Baeyens, ...
The Journal of Immunology 194 (5), 2117-2127, 2015
The emerging role of PI3K inhibitors for solid tumour treatment and beyond
C Belli, M Repetto, S Anand, C Porta, V Subbiah, G Curigliano
British journal of cancer 128 (12), 2150-2162, 2023
Fabry disease: perspectives of urinary proteomics.
M Cuccurullo, A Beneduci, S Anand, R Mignani, B Cianciaruso, A Bachi, ...
Journal of Nephrology 23, S199-212, 2010
Direct ChIP-Seq significance analysis improves target prediction
M Bansal, G Mendiratta, S Anand, R Kushwaha, RH Kim, M Kustagi, ...
BMC genomics 16, 1-10, 2015
Next generation sequencing of pooled samples: guideline for variants’ filtering. Sci Rep 6: 33735
S Anand, E Mangano, N Barizzone, R Bordoni, M Sorosina, F Clarelli, ...
Functional pro-metastatic heterogeneity revealed by spiked-scRNAseq is shaped by cancer cell interactions and restricted by VSIG1
C Bernal, M Silvano, Y Tapponnier, S Anand, C Angulo, AR i Altaba
Cell reports 33 (6), 2020
Malignant Mesothelioma
C Belli, S Anand
BoD–Books on Demand, 2012
Translational therapies for malignant pleural mesothelioma
C Belli, S Anand, G Tassi, D Fennell, L Mutti
Expert review of respiratory medicine 4 (2), 249-260, 2010
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility
M Zuccal, N Barizzone, E Boggio, L Gigliotti, M Sorosina, C Basagni, ...
Journal of Genetics and Genomics 48 (6), 497-507, 2021
The system can't perform the operation now. Try again later.
Articles 1–20